About
Technology
Issues
FAQ
Links
Official Page
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.